Dennis Greenslade

Clinical pharmacokinetics of oxaliplatin: a critical review.

Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 459 citations

Molecular Pharmacology, Oncology, Tumor Microenvironment +13

Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin

James Gilmour Morrison, Peter C. White, Sophie McDougall et al. · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 113 citations

Therapeutic Drug Monitoring, Clinical Pharmacokinetic Studies, Biochemistry +12

Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function

Chris H. Takimoto, Martin A. Graham, G. Lockwood et al. · Clinical Cancer Research · 2007 · 67 citations · Full text

Analysis of Toxicokinetic Data Using NONMEM: Impact of Quantification Limit and Replacement Strategies for Censored Data

Jeremy Hing, Steven G. Woolfrey, Dennis Greenslade et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2001 · 50 citations

Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial

Martin A. Graham, Suresh Senan, Hernani Robin et al. · Cancer Chemotherapy and Pharmacology · 1997 · 38 citations

Pharmacological Study, Medicine, Dose-escalation Strategy +7